脂联素受体激动剂AdipoRon减轻2型糖尿病相关牙周炎
本研究在饮食诱导肥胖糖尿病小鼠及脂联素敲除小鼠的实验性牙周炎模型中应用脂联素受体激动剂AdipoRon(APR),发现APR降低血糖、减少破骨细胞数量与牙槽骨丧失、抑制牙龈炎症因子CCL2和IL-6,并通过促进成骨分化与降低骨髓SDF-1促进牙槽骨再生。
要点
- APR全身给药可降低DIO糖尿病小鼠血糖并显著减少破骨细胞数量和牙槽骨丧失。
- APR减少病变牙龈组织中CCL2和IL-6的产生,并抑制破骨细胞分化。
- APR通过促进成骨分化、降低骨髓SDF-1促进牙槽骨再生,在APN敲除小鼠中同样有效。
核心结论
- APR可能作为靶向2型糖尿病相关牙周炎的多靶点有效方法。
研究设计与样本
- 在饮食诱导肥胖糖尿病小鼠和脂联素敲除小鼠中建立实验性牙周炎模型并给予APR全身治疗。
- 结合体外研究探讨APR对破骨细胞分化的抑制作用及分子机制。
主要发现
- APR全身降低DIO糖尿病小鼠血糖水平,并显著减少破骨细胞数量和牙槽骨丧失。
- APR减少病变牙龈组织中CC趋化因子配体2和白细胞介素6的产生。
- APR通过增强成骨分化和降低骨髓基质细胞衍生因子1促进牙槽骨再生。
- APR治疗脂联素敲除小鼠牙周炎获得相同结果,提示其可激活内源性APN受体发挥骨合成效应。
临床怎么用
- 提示APR可能成为同时控制血糖、抑制骨吸收和促进牙槽骨再生的候选药物,但尚需临床研究验证。
局限性
- 研究基于动物模型和体外实验,尚未在人体中验证APR对2型糖尿病相关牙周炎的疗效与安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Periodontitis is twice as prevalent in diabetics as in nondiabetics, and type 2 diabetes (T2D)-associated periodontitis is severe in many cases due to the altered and aberrant functions of bone cells in hyperglycemic conditions. Therefore, developing an effective method to halt the disease process, as well as restore and regenerate lost alveolar bone to reserve the natural teeth in diabetics, is critically important. In the current study, we applied a newly discovered adiponectin receptor agonist AdipoRon (APR) in experimental periodontitis in diabetic animal models and demonstrated the underlying molecular mechanisms. We found that when APR systemically quenched the blood sugar level in diet-induced obesity (DIO) diabetic mice, it reduced osteoclast numbers and alveolar bone loss significantly due to APR's inhibition on osteoclast differentiation shown in our in vitro studies. APR also decreased the production of proinflammatory molecules CC chemokine ligand 2 and interleukin 6 in diseased gingival tissues. On the other hand, APR promoted alveolar bone regeneration through enhancing osteogenic differentiation and decreasing stromal cell-derived factor 1 in the bone marrow that facilitates stem cell migration. Same results were achieved by APR treatment of periodontitis induced in adiponectin (APN) knockout mice, indicating the ability of APR to activate the endogenous APN receptors to exert osteoanabolic effects. In summary, our study supports the notion that APR could be used as an effective multipronged approach to target T2D-associated periodontitis.
引用
- Wu X, Qiu W, Hu Z, et al. An Adiponectin Receptor Agonist Reduces Type 2 Diabetic Periodontitis. J Dent Res. 2019. PMID: 30626266. doi:10.1177/0022034518818449
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。